Relay Therapeutics, Inc. (RLAY)

Healthcare · Biotechnology · NASDAQ

Relay Therapeutics, Inc. (RLAY) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $4.33B and a free-cash-flow yield of -7.0%. Over the most recent reported fiscal year, revenue grew 53.4%.

Market cap	$4.33B
Trailing P/E	—
FCF yield	-7.0%
Revenue growth (YoY)	+53.4%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live RLAY data on Nama Insights →